Shopping Cart
Remove All
Your shopping cart is currently empty
Thalidomide-O-amido-PEG3-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology[1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 mg | Inquiry | Inquiry | Inquiry | |
| 500 mg | Inquiry | Inquiry | Inquiry |
| Description | Thalidomide-O-amido-PEG3-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology[1]. |
| In vitro | PROTACs consist of two distinct ligands connected by a linker: one ligand targets an E3 ubiquitin ligase and the other targets the [target protein]. These compounds leverage the intracellular ubiquitin-proteasome system to selectively degrade [target proteins]. |
| Synonyms | Thalidomide-NH-PEG2-C2-NH2 |
| Molecular Weight | 404.42 |
| Formula | C19H24N4O6 |
| Cas No. | 2093416-32-9 |
| Smiles | O=C1NC(=O)C(N2C(=O)C=3C=CC=C(NCCOCCOCCN)C3C2=O)CC1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.